Alkem enters exclusive license agreement with Johns Hopkins University
The agreement is for the development and commercialisation of JHU’s novel target and technology that will help patients with colorectal cancer
The agreement is for the development and commercialisation of JHU’s novel target and technology that will help patients with colorectal cancer
Subscribe To Our Newsletter & Stay Updated